Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Nov 19, 2021)

Date Submitted: Mar 22, 2019
Open Peer Review Period: Mar 26, 2019 - May 16, 2019
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer-Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Effectiveness of engagement promoting strategies compared to no strategies in a brief intervention app targeting harmful drinking in young adults: Randomised controlled trial

  • Joanna Milward; 
  • Colin Drummond; 
  • Paolo Deluca

Background:

Electronic screening and brief intervention (eSBI) has demonstrated some effectiveness in reducing harmful alcohol consumption. However, a challenge remains as to how to sufficiently engage users with app and online based eSBI, as trials demonstrate low engagement rates. Young adults are an under-identified harmful drinking population who prefer eSBI delivered alcohol interventions. Engagement has been associated with improved clinical outcomes in the digital behaviour change literature. Therefore, identifying novel methods to engage users is warranted to improve the effectiveness of app-based eSBI interventions.

Objective:

(i) To conduct a Randomised Controlled Trial (RCT) to determine whether eSBI plus novel Engagement Promoting Strategies (EPS) compared to eSBI only was associated with higher levels of user engagement in an app targeting harmful drinking in young adults (ii) To examine the relationship between the inclusion of EPS and changes in harmful alcohol consumption and, (iii) To determine the relationship between participants who engaged and those who did not engage with the app and change in AUDIT-C score.

Methods:

An app called ‘BRANCH’ was developed, including EPS of tailoring, social features, in-app reminders and gamification. A two-arm RCT examined whether participants in the eSBI plus EPS arm (intervention) logged into BRANCH more times than the eSBI only arm (control). Participants were young adults (>=18 years old and <=30 years old) who drank alcohol at a harmful level (scored >=7 on the AUDIT-C), and lived in the UK. The primary outcome was number of logins at 28 days. Secondary outcomes included AUDIT-C at six months and engagement measured by treatment compliance (logged in > 1).

Results:

The addition of EPS to eSBI in an app targeting harmful drinking in young adults did not result in increased use, measured by number of logins compared, to the same app including only eSBI components 28 days post randomisation (P=.60). Users of the eSBI plus EPS app did not show a significant reduction in harmful drinking score as measured by the AUDIT-C score compared to users of the eSBI only app at 6-month post randomisation (P=.17). App engagers (logged in > 1) did not show a significant reduction in harmful drinking compared to non-engagers (logged in once) (P=.58).

Conclusions:

An eSBI app optimised with tailored, social and gamification features did not promote increased usage compared to eSBI only. Engagement with eSBI in young adults continues to be a barrier for designing effective eSBI apps. The associations between EPS, engagement rates and drinking outcomes remain unclear. The low engagement rates with some eSBI apps may be leading to a lack of exposure to the active behaviour change components, resulting in limited effects.

ClinicalTrial:

ISRCTN: 70980706


 Citation

Please cite as:

Milward J, Drummond C, Deluca P

Effectiveness of engagement promoting strategies compared to no strategies in a brief intervention app targeting harmful drinking in young adults: Randomised controlled trial

JMIR Preprints. 22/03/2019:14071

DOI: 10.2196/preprints.14071

URL: https://preprints.jmir.org/preprint/14071

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement